Industry flaws India's approach on ADR-related action
This article was originally published in Scrip
Executive Summary
India has underscored the significance of proactive reporting of adverse reaction-related "administrative action" of foreign regulators by "importers" of medicines as part of efforts to improve regulatory compliance in the country.